The pulmonary route is of growing interest for delivering complex molecules such as biologics. This eBook covers the evolution from traditional MDIs and nebulizers to advanced delivery systems.
From MDIs to Advanced Systems
Dosage forms have progressed from metered dose inhalers and nebulizers to sophisticated dry powder platforms.
Delivering Biologics to the Lung
Formulation and particle engineering protect fragile molecules and ensure deep lung deposition.
Local and Systemic Delivery
The lung can be used for local treatment of respiratory disease or as a route to systemic exposure.
About This White Paper
This white paper is published by Upperton and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.